**Work Experience:** 1. Engaged in clinical work in the Department of Cardiology at the First Affiliated Hospital of Sun Yat-sen University, concurrently serving as the Executive Director of the Department of Cardiology at the Nansha Campus. 2. Pioneered the introduction of interventional techniques in the province, including Shockwave intravascular lithotripsy balloon, Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Edge-to-Edge Repair (TEER), and Atrial Shunt Device implantation. In 2022, performed the nation's first trans-femoral "valve-in-valve-in-valve" TMVR procedure, the first valve-in-valve TMVR for failed mitral bioprosthesis in South China, and the first one-stop MitraClip + LAAC procedure in South China. 3. Invited to over 20 domestic centers for TAVR procedure proctoring and academic exchange, maintaining a strong academic reputation. 4. Received the "Good Doctor of the First Affiliated Hospital of Sun Yat-sen University" award in 2021. **Professional Affiliations:** * Fellow of the American College of Cardiology (FACC) * Member, Asia Pacific Structural Heart Disease Club * Member, Professional Committee of Cardiac Interventional Therapy and Rehabilitation, Chinese Association of Rehabilitation Medicine * Member, Heart Failure Professional Committee, China Medical Information Association * Vice Chair, Structural Heart Disease Branch, Greater Bay Area Heart Association * Standing Committee Member, Pan-Vascular Medicine Branch, Greater Bay Area Heart Association * Vice Chair, Cardiac Rehabilitation Branch, Guangdong Precision Medicine Application Association * Vice Chair, Youth Committee, Cardiovascular Disease Branch, Guangdong Medical Association * Chair, Youth Committee, Cardiovascular Professional Committee, Guangdong Physiological Society * Council Member, Guangdong Society of Pathophysiology; Vice Chair, Youth Committee, Cardiovascular Professional Committee * Standing Committee Member, Cardio-cerebrovascular Chronic Disease Management Committee, Guangdong Geriatric Health Association * "Kelin Rising Star" and "Kelin Elite" Talent, First Affiliated Hospital of Sun Yat-sen University **Research Activities:** 1. Long-term engagement in basic and clinical translational research on metabolic cardiovascular diseases. In recent years, has published over 40 SCI articles as corresponding/first author in high-impact journals including *Diabetes Care*, *EClinicalMedicine*, *Metabolism*, *Environment International*, *European Journal of Epidemiology*, *Cardiovascular Diabetology*, *European Journal of Preventive Cardiology*, and *Atherosclerosis*. 2. Received funding from multiple sources, including the National Natural Science Foundation of China (Young Scientists Fund), Guangdong Provincial Natural Science Foundation, and Guangdong Provincial Science and Technology Plan Project. Served as a core member participating in the National Key R&D Program project "Molecular Mechanisms of Reprogramming Chemical Small Molecules Inducing Cardiomyocyte Dedifferentiation and Their Application in Cardiac Regeneration and Repair." 3. Led the establishment of the first specialized multi-center registry database for metabolic cardiovascular diseases in South China. Initiated the world's first multi-center randomized controlled clinical trial investigating the therapeutic effects of SGLT2 inhibitors on mitral regurgitation and myocardial fibrosis in patients with heart failure. 4. Holds one invention patent (A method and system for predicting cardiovascular disease risk in prediabetes, Patent No. CN202210334081.3). Has been repeatedly invited to present research findings on the mechanisms of diabetic cardiomyopathy and novel metabolic drug therapies at the Annual Scientific Sessions of the American College of Cardiology and the Congress of the European Society of Cardiology.